Close Menu

NEW YORK ─ GenMark Diagnostics on Tuesday announced preliminary financial results for the second quarter of 2020, saying it anticipates 118 percent growth over the second quarter of 2019, driven primarily by sales associated with SARS-CoV-2 testing.

For the three months ended June 30, the firm expects its total revenues would be about $40.1 million compared to the $18.4 million it reported for Q2 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.